MedTrace Logo

Serum Surfactant Protein-D as Predictor of Disease Severity in Hospitalized COPD Patients

NCT07154953 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2025-09-10

No results posted yet for this study

Summary

evaluation of the serum levels of surfactant protein-D (SP-D), C-reactive protein (CRP), fibrinogen, and peripheral blood neutrophilic and eosinophilic counts in patients with COPD correlation of these biomarkers with clinical, functional, and radiological parameters

Conditions

Interventions

DIAGNOSTIC_TEST

Serum Surfactant Protein-D

Several studies support the use of SP-D as a marker of systemic inflammation and lung tissue damage in COPD.Measuring serum SP-D could provide a valuable tool for early detection, monitoring progression, and personalizing management of COPD patients.Surfactant protein D (SP D) as a prognostic biomarker needs further studies to validate its clinical applicability

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Heba Ahmed Abdelhafeez, Professor · Assiut University

  • HA Abdelhafeez, Professor · Assiut University

Eligibility

Min Age
40 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-12-01
Completion
2027-01-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07154953 on ClinicalTrials.gov